LA JOLLA PHARMACEUTICAL CO Insider Trading for June 2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in LA JOLLA PHARMACEUTICAL CO.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in LA JOLLA PHARMACEUTICAL CO for June 2019.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 18 2019 | LJPC | LA JOLLA PHARMACEU ... | Wellinghoff Darryl | Chief Commercial Of ... | Option Exercise | A | 9.71 | 193 | 1,874 | 193 | |
| Jun 18 2019 | LJPC | LA JOLLA PHARMACEU ... | Wellinghoff Darryl | Chief Commercial Of ... | Grant | A | 8.25 | 193 | 1,592 | 1,319 | 1.1 K to 1.3 K (+17.14 %) |
| Jun 18 2019 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Option Exercise | A | 9.71 | 193 | 1,874 | 193 | |
| Jun 18 2019 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Grant | A | 8.25 | 193 | 1,592 | 2,592 | 2.4 K to 2.6 K (+8.05 %) |
| Jun 18 2019 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Option Exercise | A | 9.71 | 96 | 932 | 96 | |
| Jun 18 2019 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Grant | A | 8.25 | 96 | 792 | 78,520 | 78.4 K to 78.5 K (+0.12 %) |
| Jun 18 2019 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Option Exercise | A | 9.71 | 69 | 670 | 69 | |
| Jun 18 2019 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Grant | A | 8.25 | 69 | 569 | 5,911 | 5.8 K to 5.9 K (+1.18 %) |
| Jun 03 2019 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Option Exercise | A | 5.39 | 126 | 679 | 126 | |
| Jun 03 2019 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Grant | A | 4.58 | 126 | 577 | 5,842 | 5.7 K to 5.8 K (+2.20 %) |
| Jun 03 2019 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Option Exercise | A | 5.39 | 174 | 938 | 174 | |
| Jun 03 2019 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Grant | A | 4.58 | 174 | 797 | 78,424 | 78.3 K to 78.4 K (+0.22 %) |
| Jun 03 2019 | LJPC | LA JOLLA PHARMACEU ... | Wellinghoff Darryl | Chief Commercial Of ... | Option Exercise | A | 5.39 | 347 | 1,870 | 347 | |
| Jun 03 2019 | LJPC | LA JOLLA PHARMACEU ... | Wellinghoff Darryl | Chief Commercial Of ... | Grant | A | 4.58 | 347 | 1,589 | 1,126 | 779 to 1.1 K (+44.54 %) |
| Jun 03 2019 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Option Exercise | A | 5.39 | 347 | 1,870 | 347 | |
| Jun 03 2019 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Grant | A | 4.58 | 347 | 1,589 | 2,399 | 2.1 K to 2.4 K (+16.91 %) |